Results 11 to 20 of about 7,517 (258)

Guidelines on the use of extracorporeal photopheresis [PDF]

, 2013
Peer ...
Arenberger, P., Assaf, C., Bagot, M., Barr, M., Berlin, G., Bohbot, A., Bruckner-Tuderman, L., Calzavara-Pinton, P., Dreno, B., Enk, A., French, L., Gniadecki, R., Gollnick, H., Greinix, H., Hertl, M., Hillen, U., Jaksch, P., Jantschitsch, C., Jung, A., Just, U., Klemke, C. -D., Knobler, R., Laroche, L., Lippert, U., Ludvigsson, J., Luger, T., Papadavid, E., Pehamberger, H., Quaglino, P., Ranki, A., Reinisch, W., Scarisbrick, J., Schwarz, T., Stadler, R., Sterry, W., Wolf, I. H., Wolf, P., Worm, M., Zic, J., Zouboulis, C. C.   +39 more
core   +3 more sources

Extracorporeal Photopheresis in Dermatological Diseases. [PDF]

Int J Mol Sci
Extracorporeal photopheresis (ECP) is an apheresis procedure that is conventionally used as a first-line treatment for cutaneous and leukemic subtypes of T-cell lymphoma, such as Sezary’s syndrome and mycosis fungoides.
Terhaar H, Saleem M, Yusuf N.
europepmc   +2 more sources

European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1. [PDF]

Journal of the European Academy of Dermatology and Venereology, 2020
Following the first investigational study on the use of extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma published in 1983, this technology has received continued use and further recognition for additional earlier as well as ...
Arenberger, P., Arun, A., Assaf, C., Bagot, M., Berlin, G., Bohbot, A., Calzavara-Pinton, P., Child, F., Cho, A., French, L.E., Gennery, A.R., Gniadecki, R., Gollnick, HPM, Greinix, H., Guenova, E., Jaksch, P., Jantschitsch, C., Klemke, C., Knobler, R., Ludvigsson, J., Papadavid, E., Scarisbrick, J., Schwarz, T., Stadler, R., Wolf, P., Zic, J., Zouboulis, C., Zuckermann, A.   +27 more
core   +4 more sources

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)

Frontiers in Immunology, 2020
As the use of hematopoietic stem cell transplantation (HSCT) has become a more widespread and effective treatment for hematological malignant and non-malignant conditions, the need to minimize the harmful effects of graft- vs.-host disease (GvHD) has ...
John A Snowden
exaly   +3 more sources

Extracorporeal photopheresis for systemic sclerosis: A meta‐analysis of randomized clinical trials

Dermatologic Therapy, 2022
Systemic sclerosis (scleroderma) (SSc) is a rare autoimmune disorder characterized by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy, phototherapy) (ECP) involves repeated exposure of peripheral blood lymphocytes to ...
T Gambichler, Frank Peinemann
exaly   +2 more sources

Evaluating a New Photopheresis System: A Comparison with Two Established Systems on Cell Yield and Collection Efficiency [PDF]

Diagnostics
Background/Objectives: Extracorporeal photopheresis (ECP) is a well-established and efficacious cell therapy for a range of diseases. The objective of this retrospective study was to compare the new Amicus Blue inline system with the Therakos Cellex ...
Orkan Kartal, Sandra Laner-Plamberger, Eva Rohde, Cornelia Mrazek, Wanda Lauth, Christoph Grabmer   +5 more
doaj   +2 more sources

Extracorporeal photopheresis for graft-versus-host disease: The role of patient, transplant, and classification criteria and hematologic values on outcome - Results from a large single-center study [PDF]

, 2014
BACKGROUND: Extracorporeal photopheresis (ECP) has been shown as active therapy for graft-versus-host disease (GVHD). STUDY DESIGN AND METHODS: The aim was to ascertain the role of ECP in 71 patients with steroid-refractory or -dependent acute and ...
Albiani, Roberto, Berger, Massimo, Fagioli, Franca, Sini, Bruno   +3 more
core   +4 more sources

Extracorporeal photopheresis for the treatment of graft rejection in 33 adult kidney transplant recipients [PDF]

, 2019
Background - Extracorporeal photopheresis (ECP) has shown encouraging results in the prevention of allograft rejection in heart transplantation. However, the role of ECP in kidney transplant (KT) rejection needs to be determined.
A. Lionet, A. Tiple, A.E. Heng, B. Pereira, C. Garrouste, C. Philipponnet, E. Merlin, G. Kosmadakis, J. Sayegh, J.F. Augusto, M. Buchler, M. Hazzan, M. Tamain, P. Grimbert   +13 more
core   +4 more sources

Extracorporeal photopheresis in the treatment of acute and chronic graft-versus-host disease: A position statement from the Turkish Society of Apheresis (TSA) [PDF]

, 2022
Graft versus host disease (GVHD) is still the most important cause of mortality and morbidity after allogeneic stem cell transplantation. Though perfect response rates are not achieved, steroids are still the first-line treat-ment.
Aksu, Salih, Demirkan, Fatih, Kaynar, Leylagül, Kozanoğlu, İlknur, Tekgündüz, Emre, Özkalemkaş, Fahir, Özkan, Hasan Atilla   +6 more
core   +2 more sources

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma

Cancers, 2023
Simple Summary Cutaneous T-cell lymphomas (CTCLs) constitute a group of rare lymphoproliferative malignancies primarily manifesting in the skin.
Nadia Ninosu, S. Melchers, Max Kappenstein, N. Booken, Inga Hansen, Maël Blanchard, E. Guenova, Chalid Assaf, Sergij Goerdt, J. Nicolay   +9 more
semanticscholar   +1 more source